CompletedNot Applicable

Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

United States24 participantsStarted 2004-11

Plain-language summary

Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female subjects 18 years of age or older. * Symmetric limited morphea. Exclusion Criteria: * Known sensitivity to fluocinonide 0.05% cream. * Clinical evidence of superinfected skin. * Immunocompromised state (including previously documented HIV). * Generalized Scleroderma. * Previous history of skin cancer. * Non-English speaking subjects.

What they're measuring

Efficacy of UVA-1 treatment vs. topical steroid.

Timeframe: 5 years

Trial details

NCT IDNCT00812188

SponsorUniversity of Texas Southwestern Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-11

View on ClinicalTrials.gov More Symmetric Limited Morphea trials